EPS Bio Technology Corp.
EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.
EPS Bio Technology Corp. (4183) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.068x
Based on the latest financial reports, EPS Bio Technology Corp. (4183) has a cash flow conversion efficiency ratio of -0.068x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-20.70 Million) by net assets (NT$304.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EPS Bio Technology Corp. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how EPS Bio Technology Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EPS Bio Technology Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EPS Bio Technology Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carolina Rush Corporation
V:RUSH
|
N/A |
|
MainStreetChamber Holdings Inc.
PINK:MSCH
|
-0.226x |
|
Kumpulan H & L High-Tech Bhd
KLSE:7033
|
0.035x |
|
RPCG PCL F
F:R4Q
|
0.048x |
|
Living Cell Technologies Limited
PINK:LVCLF
|
0.000x |
|
Fresh Grapes LLC
NYSE MKT:VINE
|
-0.396x |
|
AB Panevezio Statybos Trestas
STU:YK3
|
-0.069x |
|
Forza Land Indonesia Tbk PT
JK:FORZ
|
-0.016x |
Annual Cash Flow Conversion Efficiency for EPS Bio Technology Corp. (2019–2024)
The table below shows the annual cash flow conversion efficiency of EPS Bio Technology Corp. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$304.55 Million | NT$-32.34 Million | -0.106x | -158.90% |
| 2023-12-31 | NT$306.04 Million | NT$55.17 Million | 0.180x | +1012.22% |
| 2022-12-31 | NT$308.36 Million | NT$5.00 Million | 0.016x | -84.88% |
| 2021-12-31 | NT$299.27 Million | NT$32.08 Million | 0.107x | -58.52% |
| 2020-12-31 | NT$309.15 Million | NT$79.91 Million | 0.258x | +247.89% |
| 2019-12-31 | NT$294.07 Million | NT$21.85 Million | 0.074x | -- |